Alpa Laboratories Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Alpa Laboratories Ltd is ₹ 69.71 as of 12 Jun 15:30 . The P/E Ratio of Alpa Laboratories Ltd changed from 9 on March 2023 to 10.4 on March 2022 . This represents a CAGR of 2.93% over 5 yearsThe P/E Ratio of Sandu Pharmaceuticals Ltd changed from 33.3 on March 2023 to 0 on March 2022 . This represents a CAGR of -100.00% over 5 years The Market Cap of Alpa Laboratories Ltd changed from ₹ 113.15 crore on March 2023 to ₹ 146.23 crore on March 2022 . This represents a CAGR of 5.26% over 5 yearsThe Market Cap of Sandu Pharmaceuticals Ltd changed from ₹ 50.43 crore on March 2023 to ₹ 0 crore on March 2022 . This represents a CAGR of -100.00% over 5 years The revenue of Alpa Laboratories Ltd for the Mar '26 is ₹ 31.24 crore as compare to the Dec '25 revenue of ₹ 29.96 crore. This represent the growth of 4.27% The revenue of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Alpa Laboratories Ltd for the Mar '26 is ₹ 3.44 crore as compare to the Dec '25 ebitda of ₹ 2.42 crore. This represent the growth of 42.15% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Alpa Laboratories Ltd changed from ₹ 5.1 crore to ₹ 1.38 crore over 8 quarters. This represents a CAGR of -47.98% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Alpa Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sandu Pharmaceuticals Ltd changed from 36.33 % on March 2021 to 49.86 % on March 2025 . This represents a CAGR of 6.54% over 5 years .

About Alpa Laboratories Ltd

M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company as 'Alpa Laboratories Private Limited' on March 18, 1988 for manufacture of pharmaceutical formulations.
In 1998, the Company was converted into a Public Limited with effect from September 3, 1998.
The facility has manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the Company initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh.
The Unit commenced commercial production in the year 1999 of all types of formulations viz.
Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark 'Alpa' which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company.

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

FAQs for the comparison of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Alpa Laboratories Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Alpa Laboratories Ltd is 146 Cr while Market cap of Sandu Pharmaceuticals Ltd is 40 Cr

What are the key factors driving the stock performance of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd?

As of June 15, 2026, the Alpa Laboratories Ltd stock price is INR ₹69.71. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹41.61.

How do dividend payouts of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Alpa Laboratories Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.